Dominique Leveque
Overview
Explore the profile of Dominique Leveque including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
696
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Leveque D, Beck M, Cotton M
Lancet Oncol
. 2023 Jul;
24(7):719-720.
PMID: 37414009
No abstract available.
3.
Machkouri C, Leveque D
Bull Cancer
. 2023 May;
110(6):676-684.
PMID: 37198014
Introduction: The goal of this paper is to review the impact of marketed oral anticancer agents on the pharmacokinetics of co-administered medications in humans focusing on clinically relevant interactions. Methods:...
4.
Kokkali S, Ternant D, Kemmel V, Leveque D, Wendling F, Barthelemy P, et al.
Br J Clin Pharmacol
. 2021 Jan;
87(8):3372-3374.
PMID: 33464605
No abstract available.
5.
Leveque D, Becker G, Bilger K, Natarajan-Ame S
Clin Pharmacokinet
. 2020 Mar;
59(7):849-856.
PMID: 32112275
Dasatinib is an oral, once-daily tyrosine kinase inhibitor used in the treatment of chronic myeloid leukaemia and Philadelphia chromosome-positive acute lymphoblastic leukaemia. Dasatinib is rapidly absorbed, with the time for...
6.
7.
Leveque D, Becker G
Expert Opin Drug Saf
. 2019 Sep;
18(11):1009-1015.
PMID: 31478396
: Therapeutic drug monitoring in oncology is used to prevent major toxicities of selected anticancer agents due to overexposure by individualizing the dose based on a pharmacokinetic target. : Numerous...
8.
9.
Leveque D
Bull Cancer
. 2018 Feb;
105(2):200-203.
PMID: 29395039
This short review presents the modalities of funding of anticancer agents administrated in hospitals in France.
10.
Leveque D, Becker G, Gourieux B
Bull Cancer
. 2017 May;
104(6):497-499.
PMID: 28495129
No abstract available.